<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>AIMS: Type 2 <z:hpo ids='HP_0000819'>diabetes mellitus</z:hpo> and <z:hpo ids='HP_0002870'>obstructive sleep apnea</z:hpo> syndrome (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">OSAS</z:e>) are serious comorbidities </plain></SENT>
<SENT sid="1" pm="."><plain>Effects of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">OSAS</z:e> on diabetic microvascular complications are ongoing research subjects </plain></SENT>
<SENT sid="2" pm="."><plain>We evaluated the incidence of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">OSAS</z:e> in Type 2 <z:hpo ids='HP_0000819'>diabetes mellitus</z:hpo> patients with <z:hpo ids='HP_0000112'>nephropathy</z:hpo> and with no renal involvement </plain></SENT>
<SENT sid="3" pm="."><plain>METHODS: A total of 52 people with <z:mp ids='MP_0002055'>diabetes</z:mp> were enrolled in this study </plain></SENT>
<SENT sid="4" pm="."><plain>Patients body mass indices were calculated and fasting <z:chebi fb="105" ids="17234">glucose</z:chebi>, glycosylated <z:chebi fb="0" ids="35143">hemoglobin</z:chebi>, <z:chebi fb="20" ids="16199">urea</z:chebi>, <z:chebi fb="0" ids="16737">creatinine</z:chebi>, total <z:chebi fb="23" ids="18059">lipid</z:chebi> profile, and urinary albumin excretion were evaluated </plain></SENT>
<SENT sid="5" pm="."><plain>Full polysomnography was used to detect <z:e sem="disease" ids="C0851578,C0852564" disease_type="Disease or Syndrome;Mental or Behavioral Dysfunction" abbrv="">sleep disorders</z:e> </plain></SENT>
<SENT sid="6" pm="."><plain>RESULTS: Baseline characteristics and laboratory results of the patients were similar </plain></SENT>
<SENT sid="7" pm="."><plain>Meeting criteria for <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">OSAS</z:e> was detected in 35 of the 54 patients (67.3%) </plain></SENT>
<SENT sid="8" pm="."><plain>25 patients (48%) had mild, six patients (11.5%) had moderate, and four patients (7.7%) had severe <z:e sem="disease" ids="C0851578,C0852564" disease_type="Disease or Syndrome;Mental or Behavioral Dysfunction" abbrv="">sleep disorders</z:e> </plain></SENT>
<SENT sid="9" pm="."><plain>There was no significant relationship between respiratory obstructive parameters and <z:mp ids='MP_0002959'>microalbuminuria</z:mp> (R=0.91, p=0.362) </plain></SENT>
<SENT sid="10" pm="."><plain>Substantial correlation was detected between lower values of serum <z:chebi fb="0" ids="17855">triglyceride</z:chebi> levels and lower respiratory indices (R=0.299, p=0.031) </plain></SENT>
<SENT sid="11" pm="."><plain>CONCLUSIONS: In type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> accompanying <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">OSAS</z:e> affects <z:chebi fb="105" ids="17234">glucose</z:chebi> regulation but its effect on <z:hpo ids='HP_0000112'>nephropathy</z:hpo> development is currently a subject of research </plain></SENT>
</text></document>